The U.S. Centers for Disease Control and Prevention (CDC) has activated enhanced Ebola screening at additional major airports in response to an ongoing outbreak in the Democratic Republic of the Congo (DRC) that has surpassed 1,000 suspected and confirmed cases. Starting in late May 2026, travelers who have been in the DRC, Uganda, or South Sudan within the past 21 days must route their arrivals through Washington Dulles International Airport (IAD), Hartsfield-Jackson Atlanta International Airport (ATL), or George Bush Intercontinental Airport (IAH) in Houston for temperature checks, symptom questionnaires, contact tracing, and observation using no-contact thermometers. Those without symptoms proceed to final destinations, while symptomatic individuals face further medical evaluation. This builds on earlier restrictions that initially funneled passengers exclusively through Dulles and includes a temporary ban on entry for most non-U.S. citizens and recent expansions affecting green card holders. Official CDC guidance stresses these measures layer atop overseas screening and post-arrival monitoring, with no linked Ebola cases currently in the United States. However, two American physicians exposed or infected in the region were medically evacuated abroad rather than to U.S. facilities, with decisions on future evacuations to be handled case-by-case to minimize transmission risk.

This development echoes the 2014 Ebola panic in the U.S., when similar airport protocols and media coverage triggered widespread public fear despite low domestic risk. The one-sentence reality travelers immediately grasp: recent travel to these three nations now funnels you into specialized screening hubs or risks denied entry, prompting many to self-monitor symptoms, cancel non-essential trips, or seek medical clearance preemptively. Deeper connections include questions of outbreak scale—bordering countries like Uganda and South Sudan raise fears of regional spread via porous borders and strained local health systems—alongside U.S. preparedness gaps exposed in past drills. While mainstream coverage frames this as prudent precaution, it also highlights tensions in global health security: how routine expansion of screening infrastructure can normalize heightened biosurveillance and subtly erode travel freedoms under the banner of safety. Sources confirm the outbreak's severity and the precise implementation timeline, underscoring that while transmission to the U.S. remains unlikely, the visible theater of airport screenings amplifies visceral public concern over invisible viral threats.